Clinical Trial Results: Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes

View source ↗

Summary

A completed clinical trial examines pre-diagnosis GLP-1 receptor agonist use and post-cancer mortality in adults with obesity and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms
• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Chung Shan Medical University | Conditions: Obesity & Overweight, Diabetes Mellitus Type 2 | Status: COMPLETED | Results posted: 2026-08-17